Rose Health provides a HIPAA-compliant mental health patient monitoring app and provider dashboard powered by patent-pending AI and natural language processing that produces a proprietary "Rose score." The platform is informed by clinical trials and research at Johns Hopkins and is positioned to detect speech and emotion markers tied to depression and mood disorders. The company plans to use new funding to support customer acquisition, new feature development, creation of a child/adolescent version of the platform, and an employer program pilot with the Visiting Nurse Service of New York. Visiting Nurse Service of New York (VNSNY) will serve as both investor and early client, planning to integrate the app with its services. Rose says the product supports remote patient monitoring for depression and anxiety and cites evidence-based studies showing positive outcomes. The company targets the estimated 43 million Americans experiencing mental illnesses.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Jan 2021